feedback

Course Director

Amir T. Fathi, MD
Amir T. Fathi, MD

Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Faculty

Richard Dickens
Richard Dickens, MS, LCSW-R

CancerCare
New York, New York

Jenna Moran
Jenna Moran, NP

Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / MOC / CNE
Credit Amount:0.75 Credits
Release Date:2018-Dec-05
Expiration Date:2019-Dec-04
Estimated Time for Completion:60 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

In this activity, experts in acute myeloid leukemia discuss the oncologist, nurse, and patient partnership in AML management and its role in integrating targeted therapy into care.

Upon completion of this activity, participants will be able to:
  • Identify clinically relevant mutations, mutation testing techniques, and patient-related prognostic features useful for therapy selection in acute myeloid leukemia
  • Describe updated evidence about the efficacy of novel targeted strategies, including FLT3, IDH, and BCL-2 inhibitors, among other strategies, in patients with acute myeloid leukemia
  • Select appropriate targeted options for the management of acute myeloid leukemia while considering patients’ preferences and concerns
  • Collaborate with other members of the hematology-oncology team to manage treatment-related adverse events associated with novel targeted agents to treat acute myeloid leukemia, including through patient education strategies and medical interventions

Target Audience

This activity has been designed to meet the educational needs of hematologists, oncologists, nurse practitioners, physician assistants, oncology nurses, and other clinicians involved in the treatment of patients with acute myeloid leukemia.

Nursing Education Purpose Statement

The purpose of this activity is to improve knowledge and competence of nurses concerning the treatment of acute myeloid leukemia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC/CNE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: December 5, 2018 - December 4, 2019
Time to Complete: 60 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/MOC/CNE activity during the past 12 months.

Course Director and Moderator

Amir T. Fathi, MD
Director of Leukemia
Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Amir T. Fathi, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Agios, Inc.; Astellas Pharma US, Inc.; Celgene Corporation; and Takeda Pharmaceutical Company Limited.
Advisory Board for Astellas Pharma US, Inc.

Amir T. Fathi, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: developmental FLT3, IDH1/2, and BCL-2 inhibitors being tested in clinical trials for newly diagnosed and relapsed/refractory AML.

Faculty

Richard Dickens, MS, LCSW-R
Director of Client Advocacy
CancerCare
New York, New York

Richard Dickens, MS, LCSW-R, has no financial interests/relationships or affiliations in relation to this activity.

Richard Dickens, MS, LCSW-R, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: developmental FLT3, IDH1/2, and BCL-2 inhibitors being tested in clinical trials for newly diagnosed and relapsed/refractory AML.

Jenna Moran, NP
Nurse Practitioner
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Jenna Moran, NP, has no financial interests/relationships or affiliations in relation to this activity.

Jenna Moran, NP, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: developmental FLT3, IDH1/2, and BCL-2 inhibitors being tested in clinical trials for newly diagnosed and relapsed/refractory AML.

CME/MOC/CNE Reviewers

Shaina Rozell, MD, MPH
Shaina Rozell, MD, MPH, CME/MOC Reviewer, has no financial interests/relationships or affiliations in relation to this activity.

Janice Trainor-Tellier, MSN, RN
Janice Trainor-Tellier, MSN, RN, CNE/MOC Reviewer, has no financial interests/relationships or affiliations in relation to this activity.

Tracy L. Greene, MSN, RN, FNP-C
Tracy L. Greene, MSN, RN, FNP-C, Lead Nurse Planner, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/MOC/CNE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME/MOC/CNE activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME/MOC/CNE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME’s Program and Activity Reporting System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.

Registered Nurse Designation

Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Successful completion of this continuing nursing education activity will be awarded 0.75 contact hours.

Providership


This CME/MOC/CNE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by independent educational grants from AbbVie and Celgene Corporation.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/MOC/CNE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.